-
Massive Acquisition Of Obesity Drug Developer, Clinical Programs For Rare Genetic Disease, Clinical Translation Of Gene Therapies, More
Clinical Research News | Novo Nordisk acquires Inversago Pharma and the development of an appetite regulator; ADARx Pharmaceuticals will advance clinical programs on a rare genetic disease with new funding; Kriya Therapeutics plans to use Series C funding for clinical translation of gene therapies; more.
Aug 30, 2023
-
AI-Powered inClinico Aims To Solve The Phase 2-To-3 Transition Problem
Clinical Research News | Insilico Medicine recently broke the news that one of its platforms, powered by artificial intelligence (AI), succeeded in predicting the outcomes of several phase 2 clinical trials.
Aug 24, 2023
-
Novel Biomarker Tracks Tightly With Tau Tangles In Alzheimer’s Disease
Clinical Research News | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.
Aug 23, 2023
